HCV-Specific Cellular Immunity in Acute Hepatitis C
HCV-Specific Cellular Immunity in Acute Hepatitis C
批准号:
7014194
负责人:
Christopher M. Walker
金额:
$39.99万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-06-30
关键词:
MHC class I antigenMHC class II antigenPancell differentiationcell linecellular immunitycooperative studycytotoxic T lymphocyteflow cytometrygene mutationhelper T lymphocytehepatitis C virushost organism interactionimmune responseimmunogeneticsimmunologic memorymicroorganism immunologyphenotypevirus replication
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We recently demonstrated that successful resolution of acute hepatitis C in chimpanzees primes a protective memory T cell response. Depletion of memory CD8+ T cells with subset-specific antibodies immediately before re-infection resulted in prolonged viremia. Infections never resolved if CD4+ T cells were depleted. Indeed, without helper activity memory CD8+ T cells selected for escape mutations in MHC class I restricted epitopes of the virus. These results indicate an essential role for both T cell subsets in control of HCV replication but why they usually fail is not known. T cell responses appear to focus on a limited set of MHC class I and II epitopes at the point infection resolves and later broaden to include sub-dominant epitopes. Thus, while the response appears multi-specific, it effectively targets a limited set of dominant epitopes when virus replication (and errors by the RNA polymerase) are at a peak. Specific aim 1 is to determine if this causes mutational escape of dominant MHC class II epitopes.
Mutational escape will be compared with other potential mechanisms of CD4+ T cell silencing including failure to expand, acquire function, or follow a normal differentiation program after antigen activation. MHC class II tetramer technology adapted to chimpanzees will facilitate the analysis. Specific aim 2 is to identify defects in CD8+ T cells during acute hepatitis C and to determine if they occur coincident with CD4+ T cell loss. Finally, specific aim 3 will test the limits of T cell protection against persistence by rechallenging immune animals with virus variants that
contain adaptive mutations in dominant MHC class I and II epitopes. Our three specific aims are to: Specific Aim 1. Compare how mutational escape in MHC class II epitopes versus functional defects in CD4+ T cells contribute to persistence of HCV. Specific Aim 2. Determine how HCV-specific CD8+ T cells are inactivated during acute hepatitis C and whether these defects are precipitated by the sudden loss of CD4+ T cell help that is characteristic of infections that persist. Specific Aim 3. Determine if transmission of HCV variants containing escape mutations in dominant MHC class I or II epitopes can subvert protective memory T cell responses in immune chimpanzees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strategies to enhance vaccine-primed T cell immunity against HCV
-
批准号:10797241
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2021
-
负责人:Christopher M. Walker
-
依托单位:
Strategies to enhance vaccine-primed T cell immunity against HCV
-
批准号:10205550
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2021
-
负责人:Christopher M. Walker
-
依托单位:
Strategies to enhance vaccine-primed T cell immunity against HCV
-
批准号:10409761
-
项目类别:
-
资助金额:$63.37万
-
财政年份:2021
-
负责人:Christopher M. Walker
-
依托单位:
T Cell Immunity and HCV Infection Outcome
-
批准号:9346587
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2016
-
负责人:Christopher M. Walker
-
依托单位:
T Cell Immunity and HCV Infection Outcome
-
批准号:10000824
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2016
-
负责人:Christopher M. Walker
-
依托单位:
T Cell Immunity and HCV Infection Outcome
-
批准号:9325247
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2016
-
负责人:Christopher M. Walker
-
依托单位:
T Cell Immunity and HCV Infection Outcome
-
批准号:9759758
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2016
-
负责人:Christopher M. Walker
-
依托单位:
Persistent hepatitis C virus replication and T cell immunity in pregnancy
-
批准号:8321226
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2012
-
负责人:Christopher M. Walker
-
依托单位:
Persistent hepatitis C virus replication and T cell immunity in pregnancy
-
批准号:8604366
-
项目类别:
-
资助金额:$58.45万
-
财政年份:2012
-
负责人:Christopher M. Walker
-
依托单位:
Persistent hepatitis C virus replication and immunity in pregnancy
-
批准号:10413150
-
项目类别:
-
资助金额:$60.92万
-
财政年份:2012
-
负责人:Christopher M. Walker
-
依托单位:
Persistent hepatitis C virus replication and T cell immunity in pregnancy
-
批准号:8416956
-
项目类别:
-
资助金额:$54.95万
-
财政年份:2012
-
负责人:Christopher M. Walker
-
依托单位:
Persistent hepatitis C virus replication and T cell immunity in pregnancy
-
批准号:8337875
-
项目类别:
-
资助金额:$61.08万
-
财政年份:2011
-
负责人:Christopher M. Walker
-
依托单位:
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION
-
批准号:8357654
-
项目类别:
-
资助金额:$3.21万
-
财政年份:2011
-
负责人:Christopher M. Walker
-
依托单位:
INNATE AND ADAPTIVE IMMUNE RESPONSE TO HAV
-
批准号:8357674
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2011
-
负责人:Christopher M. Walker
-
依托单位:
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION
-
批准号:8172660
-
项目类别:
-
资助金额:$5.44万
-
财政年份:2010
-
负责人:Christopher M. Walker
-
依托单位:
INNATE AND ADAPTIVE IMMUNE RESPONSE TO HAV
-
批准号:8172693
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2010
-
负责人:Christopher M. Walker
-
依托单位:
Strategies to overcome immunity in gene therapy of DMD
-
批准号:8032753
-
项目类别:
-
资助金额:$53.11万
-
财政年份:2010
-
负责人:Christopher M. Walker
-
依托单位:
HCV REPLICATION AND IMMUNITY
-
批准号:8172643
-
项目类别:
-
资助金额:$4.8万
-
财政年份:2010
-
负责人:Christopher M. Walker
-
依托单位:
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION
-
批准号:7957915
-
项目类别:
-
资助金额:$1.68万
-
财政年份:2009
-
负责人:Christopher M. Walker
-
依托单位:
HCV REPLICATION AND IMMUNITY
-
批准号:7957884
-
项目类别:
-
资助金额:$10.16万
-
财政年份:2009
-
负责人:Christopher M. Walker
-
依托单位:
海外基金